Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Cheng, Jianfeng ^a   Joyce, Andrew ^b   Yates, Katherine ^c   Aouizerat, Bradley ^d   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Venebio Group LLC   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID DERIVATIVE; BIOLOGICAL MARKER; CHROMAN DERIVATIVE; GAMMA CARBOXYETHYLHYDROXYCHROMAN; GAMMA GLUTAMYLISOLEUCINE; GAMMA GLUTAMYLLEUCINE; GAMMA GLUTAMYLTRANSFERASE; GAMMA GLUTAMYLVALINE; GLUTATHIONE; INDOLEPROPIONIC ACID; PHENYLPROPIONIC ACID DERIVATIVE; PLACEBO; SPHINGOSINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PILOT STUDY; PREDICTION;

ADULT; BIOLOGICAL MARKERS; FATTY LIVER; FEMALE; HUMANS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; VITAMIN E;

EID: 84866556907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044106     Document Type: Article

References (26)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
2. Ludwig J, Viggiano TR, McGill DB, Oh BJ, (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438.
3. Adams LA, Sanderson S, Lindor KD, Angulo P, (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol pp. 132-138.
4. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, et al. (2006) Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology pp. 865-873.
5. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, et al. (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192.
6. Youssef W, McCullough AJ, (2002) Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis 13: 17-30.
7. Mitsuyoshi H, Itoh Y, Okanoue T, (2006) [Role of oxidative stress in non-alcoholic steatohepatitis]. Nippon Rinsho 64: 1077-1082.
8. Miele L, Gabrieli ML, Forgione A, Vero V, Gallo A, et al. (2006) [Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?]. Recenti Prog Med 97: 1-5.
9. Arun J, Sanyal MD, Naga Chalasani MB, Kris V, Kowdley MD, et al. (2010) Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. The new england journal o f medicine 362;18.
10. Bedossa P, Dargère D, Paradis V, (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38: 1449-1457.
11. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology pp. 1898-1906.
12. Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, et al. (2004) A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2: 1107-1115.
13. Sachdeva RTB, Wang X, Ma J, Jones KH, Hatcher PG, et al. (2005) Tocopherol metabolism using thermochemolysis: chemical and biological properties of gamma-tocopherol, gamma-carboxyethyl-hydroxychroman, and their quinones. Chem Res Toxicol 18: 1018-1025.
14. Garcia-Ruiz C, (2006) Mitochondrial glutathione: hepatocellular survival-death switch. J Gastroenterol Hepatol pp. S3-6.
15. Nobili V, Gaeta LM, Tozzi G, Comparcola D, Sartorelli MR, et al. (2005) Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta pp. 105-111.
16. Teismann HLMaP, (2009) Glutathione-a review on its role and significance in Parkinson's disease. The FASEB Journal 23: 3263-3272.
17. Li N, Oberley TD, (1998) Modulation of Antioxidant Enzymes,Reactive Oxygen Species, and Glutathione Levels in Manganese Superoxide Dismutase-Overexpressing NIH/3T3 Fibroblasts During the Cell Cycle. JOURNAL OF CELLULAR PHYSIOLOGY 177: 148-160.
18. Djavaheri-Mergny M, Rouillard D, Wietzerbin J, (2002) Gamma-glutamyl transpeptidase activity mediates NF-kappaB activation through lipid peroxidation in human leukemia U937 cells. Mol Cell Biochem 232 (1-2):: 103-111.
19. (2004) Committee DDIC. Action plan for liver diseases. In: services. USDoHaH, editor.
20. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95.
21. Colell A, García-Ruiz C, Miranda M, Ardite E, Marí M, et al. (1998) Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 115: 1541-1551.
22. Marí M, Fernández-Checa JC, (2007) Sphingolipid signalling and liver diseases. Liver Int 27 (4):: 440-450.
23. Marí M, Colell A, Morales A, Pañeda C, Varela-Nieto I, et al. (2004) Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest 113: 895-904.
24. Marí M, Caballero F, Colell A, Morales A, Caballeria J, et al. (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4: 185-198.
25. Attwood G, Li D, Pacheco D, Tavendale M, (2006) Production of indolic compounds by rumen bacteria isolated from grazing ruminants. J Appl Microbiol 100: 1261-1271.
26. Hardeland R, Poeggeler B, Fuhrberg B, Holst S, Coto-Montes A, (1999) Indole-3-pyruvic and-propionic acids, kynurenic acid, and related metabolites as luminophores and free-radical scavengers. Adv Exp Med Biol 467: 389-395.